89 completed. 89 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 89 | Completed 89 |
Follow Leukemia: new trials by email Literature Review of Leukemia trials Research Report on Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation Asciminib - Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase | Phase 4 | Completed | Novartis Pharmaceuticals | 85 | 2024-11-28 | 2026-06-08 |
| Stopping Antibiotics After 3 Days for the Treatment of High-risk FEbrile Neutropenia Comparison short vs extended EBAT treatment group - Neutropenia, Febrile | Phase 4 | Completed | Universitaire Ziekenhuizen KU Leuven | 450 | 2024-02-26 | 2026-10-23 |
| The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery Bridion 200 MG in 2 ML Injection, Pyridostigmine Bromide 5 MG/ML - Emergence Delirium, Strabismus | Phase 4 | Completed | Konkuk University Medical Center | 76 | 2023-12-01 | 2026-07-15 |
| A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia inotuzumab ozogamicin - Acute Lymphoblastic Leukemia | Phase 4 | Completed | Pfizer | 44 | 2023-02-24 | 2025-12-03 |
| Venetoclax With Hypomethylating Agents in Newly Diagnosed AML Unfit for Intensive Chemotherapy Venetoclax, Azacitidine, Decitabine - Acute Myeloid Leukemia | Phase 4 | Completed | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 24 | 2022-06-01 | 2026-08-21 |
| Ropeginterferon for Treatment Free Remission Ropeginterferon - CML (Chronic Myelogenous Leukemia) | Phase 4 | Completed | Dong-Wook Kim | 65 | 2021-11-30 | 2025-08-22 |
| Acalabrutinib Study in Indian Patients With Chronic Lymphocytic Leukaemia & Relapsed and Refractory Mantle Cell Lymphoma Acalabrutinib capsule - Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma | Phase 4 | Completed | AstraZeneca | 103 | 2021-07-14 | 2024-11-22 |
| Nalbuphine Versus Ketamine for Prevention of Emergence Agitation After Sevoflurane in Children Undergoing Tonsillectomy Nalbuphine Injection, Ketamine, Saline - Pediatric ALL, Pediatric Anesthesia | Phase 4 | Completed | Ain Shams University | 90 | 2021-03-25 | 2022-01-04 |
| Regional Anesthesia for Totally Awake Upper Limb Surgery in PEDiatric Population local anaesthetic injection - Surgery, Anesthesia, Local | Phase 4 | Completed | GCS Ramsay Santé pour l'Enseignement et la Recherche | 100 | 2020-10-14 | 2026-07-16 |
| A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients inotuzumab ozogamicin-dose level 2, Inotuzumab ozogamicin-dose level 1 - Leukemia, Precursor b-Cell Lymphoblastic Leukemia-Lymphoma | Phase 4 | Completed | Pfizer | 102 | 2019-07-01 | 2023-11-22 |
| A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion Ibrutinib 420 mg, Ibrutinib 560 mg - Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell | Phase 4 | Completed | Johnson & Johnson Private Limited | 75 | 2019-06-26 | 2025-05-25 |
| Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever Ceftazidime Injection, Cefepime Injection - Neutropenia, Febrile, Leukemia | Phase 4 | Completed | Universitas Indonesia | 72 | 2019-03-01 | 2019-12-06 |
| Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric ECMO Bivalirudin, Unfractionated heparin - Extracorporeal Membrane Oxygenation Complication, Pediatric ALL | Phase 4 | Completed | University of Texas Southwestern Medical Center | 30 | 2018-03-25 | 2023-01-31 |
| MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study MP Diagnostics HTLV Blot 2.4 - HTLV-I Infections, HTLV-II Infections | Phase 4 | Completed | MP Biomedicals, LLC | 150 | 2018-01-15 | 2018-09-13 |
| A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT Vitamin D3, Standard Vitamin D3 Supplementation - Vitamin D Deficiency, Stem Cell Transplant Complications | Phase 4 | Completed | Phoenix Children's Hospital | 49 | 2017-11-01 | 2020-11-17 |
| Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge budesonide, beclomethasone - Asthma, Pediatric ALL | Phase 4 | Completed | New York City Health and Hospitals Corporation | 43 | 2017-09-10 | 2019-07-18 |
| Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML Fludarabine, Cytarabine - Acute Myeloid Leukemia, Core-Binding Factor | Phase 4 | Completed | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 68 | 2017-01-01 | 2024-10-01 |
| King's Invasive Aspergillosis Study II Posaconazole - Aplastic Anemia, Leukemia, Myeloid, Acute | Phase 4 | Completed | King's College Hospital NHS Trust | 120 | 2016-12-07 | 2020-04-02 |
| A Study of Dasatinib as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (CML-CP) Dasatinib Tablets - Chronic Myelogenous Leukemia - Chronic Phase | Phase 4 | Completed | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 62 | 2016-05-10 | 2021-06-14 |
| Study Assessing Deep Molecular Response in Adult Patients With CML in Chronic Phase Treated With Nilotinib Firstline. Nilotinib - Chronic Myeloid Leukemia | Phase 4 | Completed | Novartis Pharmaceuticals | 171 | 2016-02-18 | 2022-07-22 |
Showing 20 of 89. Sign in to see all of them.
Precursor Cell Lymphoblastic Leukemia-Lymphoma (30) · Leukemia, Myeloid, Acute (19) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (16) · Leukemia, Lymphocytic, Chronic, B-Cell (8) · Myelodysplastic Syndromes (7) · Lymphoma (6) · Leukemia, Myeloid, Chronic-Phase (4) · Leukemia, Promyelocytic, Acute (4) · Neoplasm, Residual (4) · Recurrence (4) · Lymphoma, Mantle-Cell (3) · Lymphoma, Non-Hodgkin (3) · Neoplasms (3) · Neutropenia (3)
Hemic and Lymphatic Diseases (89) · Neoplasms by Histologic Type (89) · Hematologic Diseases (87) · Neoplasms (86) · Immune System Diseases (46) · Immunoproliferative Disorders (43) · Lymphatic Diseases (43) · Lymphoproliferative Disorders (43) · Leukemia, Myeloid (41) · Pathological Conditions, Signs and Symptoms (40) · Leukemia, Lymphoid (38) · Pathologic Processes (37) · Disease Attributes (29) · Chronic Disease (27)
Cytarabine (20) · Vincristine (15) · Cyclophosphamide (14) · Methotrexate (13) · Dexamethasone (12) · Mercaptopurine (12) · Asparaginase (11) · Daunorubicin (10) · nilotinib (9) · Doxorubicin (8) · Prednisolone (8) · Granulocyte Colony-Stimulating Factor (7) · Idarubicin (7) · Etoposide (6) · Imatinib Mesylate (6)
PETHEMA Foundation (14) · Novartis Pharmaceuticals (13) · Goethe University (5) · Pfizer (3) · Technische Universität Dresden (3) · Johann Wolfgang Goethe University Hospital (2) · Ain Shams University (1) · Astes (1) · AstraZeneca (1) · Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1) · Bristol-Myers Squibb (1) · Canadian Immunization Research Network (1) · Centre Hospitalier Universitaire, Amiens (1) · Charite University, Berlin, Germany (1) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)
Spain (20) · Germany (19) · United States (19) · France (11) · China (9) · Belgium (6) · Sweden (6) · United Kingdom (6) · Canada (5) · Italy (5) · Poland (5) · South Korea (5) · Austria (4) · Finland (4) · Hungary (4)
Dieter Hoelzer, MD,PhD (4) · Sanz Miguel Angel, Dr (4) · Bastida Pilar, Dr (2) · Dieter Hoelzer, MD, PhD (2) · Gerhard Ehninger, MD (2) · Xiaofan Zhu, MD (2) · Alessandra Iurlo, MD (1) · Alexander Ngwube, MD (1) · Ali McMichael, MD (1) · Andreas Hochhaus, Professor, MD (1) · Arnon Nagler, MD (1)
PMID 36064577, PMID 19144982, PMID 22442346, PMID 22493293, PMID 23024237, PMID 24923295, PMID 27561722, PMID 28751559, PMID 28945881, PMID 14752084, PMID 15014526, PMID 15158091, PMID 15257960, PMID 17223475, PMID 18056840, PMID 19564304, PMID 19720924, PMID 20220063, PMID 20393132, PMID 20442365, PMID 21148082, PMID 21266057, PMID 21670449, PMID 21775497, PMID 21828124, PMID 21940824, PMID 22197676, PMID 22198540, PMID 22241828, PMID 22290953, PMID 22965967, PMID 23630210, PMID 23733379, PMID 23775972, PMID 24117042, PMID 24752047, PMID 25170123, PMID 25253770, PMID 25359988, PMID 25547501, PMID 25975975, PMID 26001791, PMID 26377300, PMID 26863635, PMID 26993758, PMID 27006491, PMID 27771544, PMID 28235771, PMID 28522574, PMID 28529313
2009 (3), 2015 (1), 2018 (1), 2019 (1), P30CA021765 (1), R01CA078957 (1), R01CA091912 (1), U01CA081445 (1)